DeepMed Research

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

GATA6 Expression as a Predictor of Response to Peri-Operative Chemotherapy in Resectable Pancreatic Adenocarcinoma

Not Applicable

Active, not recruiting

Conditions: Resectable Pancreatic Cancer

Interventions: Drug: Modified Folforinox (mFFX)

First Posted Date: 2020-07-16

Last Posted Date: 2023-11-27

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 84

Registration Number: NCT04472910

Locations: 🇨🇦
Ottawa Hospital, Ottawa, Ontario, Canada
🇨🇦
Jewish General Hospital, Montréal, Quebec, Canada
🇨🇦
BC Cancer Agency Vancouver, Vancouver, British Columbia, Canada

and more 5 locations

Pancreatic Adenocarcinoma Signature Stratification for Treatment

Phase 2

Active, not recruiting

Conditions: Pancreatic Cancer Metastatic
Pancreatic Ductal Adenocarcinoma
Advanced Pancreatic Cancer

Interventions: Drug: Folfirinox
Drug: Gemcitabine/nab-paclitaxel

First Posted Date: 2020-07-14

Last Posted Date: 2024-04-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 150

Registration Number: NCT04469556

Locations: 🇺🇸
Dana Farber Cancer Institute, Boston, Massachusetts, United States
🇺🇸
Memorial Sloan Kettering Cancer Center, New York, New York, United States
🇺🇸
Northwell Health, New Hyde Park, New York, United States

and more 3 locations

Semaglutide for the Treatment of Cognitive Dysfunction in Major Depressive Disorder

Phase 2

Active, not recruiting

Conditions: Major Depressive Disorder

Interventions: Biological: Placebo
Biological: Semaglutide

First Posted Date: 2020-07-10

Last Posted Date: 2024-08-13

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 72

Registration Number: NCT04466345

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Functional Electrical Stimulation for Facial Muscles

Not Applicable

Terminated

Conditions: Facial Nerve Paresis

Interventions: Other: Application of FES to the Face

First Posted Date: 2020-07-07

Last Posted Date: 2024-03-20

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 1

Registration Number: NCT04457492

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Expert Behaviors USGRA

Conditions: Anesthesia Education

First Posted Date: 2020-07-02

Last Posted Date: 2020-07-31

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 190

Registration Number: NCT04454801

At Home Monitoring for Patients With Covid19

Not Applicable

Completed

Conditions: Coronavirus

Interventions: Device: Covidfree@home

First Posted Date: 2020-07-01

Last Posted Date: 2025-01-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 432

Registration Number: NCT04453774

Locations: 🇨🇦
Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada
🇨🇦
University Health Network, Toronto, Ontario, Canada

Study of Decidual Stromal Cells to Treat COVID-19 Respiratory Failure

Not Applicable

Completed

Conditions: COVID-19
Acute Respiratory Distress Syndrome

Interventions: Biological: Decidual Stromal Cells (DSC)

First Posted Date: 2020-06-30

Last Posted Date: 2024-02-05

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 19

Registration Number: NCT04451291

Locations: 🇨🇦
Brampton Civic Hospital, Brampton, Ontario, Canada
🇨🇦
Etobicoke General Hospital, Etobicoke, Ontario, Canada
🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Efficacy and Safety of VPM1002 in Reducing SARS-CoV-2 (COVID-19) Infection Rate and Severity

Phase 3

Completed

Conditions: SARS-CoV-2 Infection

Interventions: Other: Placebo
Biological: VPM1002

First Posted Date: 2020-06-19

Last Posted Date: 2022-04-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 122

Registration Number: NCT04439045

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Virtual Assistant for COVID-19 PPE

Not Applicable

Conditions: COVID-19

Interventions: Other: Human Coach first, then Virtual Assistant
Other: Virtual Assistant first, then Human Coach

First Posted Date: 2020-06-17

Last Posted Date: 2021-01-08

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 50

Registration Number: NCT04435275

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Treatment of Bipolar Depression With Pentoxifylline

Early Phase 1

Completed

Conditions: Bipolar Depression

Interventions: Drug: Pentoxifylline 400 MG

First Posted Date: 2020-06-04

Last Posted Date: 2022-04-15

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 6

Registration Number: NCT04417049

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy